ArticlePDF AvailableLiterature Review

Neurotoxic envenoming by South American coral snake (Micrurus lemniscatus helleri): case report from eastern Ecuador and review

Authors:
  • Hospital Nacional de Niños, Costa Rica

Abstract and Figures

A man bitten by a large coral snake (Micrurus lemniscatus helleri) in the Amazon basin of Ecuador developed persistent excruciating pain in the bitten arm. On admission to hospital less than 30 min later, he had a polymorphonuclear leucocytosis, thrombocytopenia and mildly prolonged prothrombin time/partial thromboplastin time. Not until 14 h after the bite did he develop the first signs of neurotoxicity. Despite treatment with specific antivenom 50 h after the bite, he required oxygen for respiratory failure 60 h, and 6 h of mechanical ventilation 72 h, after the bite. Over the next 38 h, he required two further intubations and periods of assisted ventilation before being airlifted to a tertiary referral hospital. Complications included bacterial pneumonia, pneumothorax, bronchial obstruction by mucus plugs and mild rhabdomyolysis. He was discharged from hospital 15 days after the bite with persistent limb weakness and urinary incontinence but eventually recovered. The interesting and unusual features of this case (severe local pain, very slow evolution of neurotoxic envenoming, persistent thrombocytopenia and mild coagulopathy) are discussed in the context of what is known of the composition of Micrurus venoms and the small clinical literature on envenoming from their bites.
Content may be subject to copyright.
This article appeared in a journal published by Elsevier. The attached
copy is furnished to the author for internal non-commercial research
and education use, including for instruction at the authors institution
and sharing with colleagues.
Other uses, including reproduction and distribution, or selling or
licensing copies, or posting to personal, institutional or third party
websites are prohibited.
In most cases authors are permitted to post their version of the
article (e.g. in Word or Tex form) to their personal website or
institutional repository. Authors requiring further information
regarding Elsevier’s archiving and manuscript policies are
encouraged to visit:
http://www.elsevier.com/copyright
Author's personal copy
Transactions of the Royal Society of Tropical Medicine and Hygiene (2008) 102, 1127—1132
available at www.sciencedirect.com
journal homepage: www.elsevierhealth.com/journals/trst
Neurotoxic envenoming by South American coral
snake (Micrurus lemniscatus helleri): case report
from eastern Ecuador and review
Stephen R. Manocka, German Suareza, David Graham a,
Mar
´
ıa L. Avila-Aguero b, David A. Warrellc,
aHospital Vozandes del Oriente, Shell, Pastaza, Ecuador
bHospital Nacional de Ni˜
nos and Minister of Health, San Jos´
e, Costa Rica
cUniversity of Oxford, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK
Received 2 January 2008; received in revised form 27 March 2008; accepted 28 March 2008
Available online 16 May 2008
KEYWORDS
South American coral
snake;
Micrurus lemniscatus
helleri;
Snake bite;
Antivenom;
Anticholinesterase;
Ecuador
Summary A man bitten by a large coral snake (Micrurus lemniscatus helleri) in the Amazon
basin of Ecuador developed persistent excruciating pain in the bitten arm. On admission to
hospital less than 30 min later, he had a polymorphonuclear leucocytosis, thrombocytopenia and
mildly prolonged prothrombin time/partial thromboplastin time. Not until 14 h after the bite did
he develop the first signs of neurotoxicity. Despite treatment with specific antivenom 50 h after
the bite, he required oxygen for respiratory failure 60 h, and 6h of mechanical ventilation 72 h,
after the bite. Over the next 38 h, he required two further intubations and periods of assisted
ventilation before being airlifted to a tertiary referral hospital. Complications included bacterial
pneumonia, pneumothorax, bronchial obstruction by mucus plugs and mild rhabdomyolysis. He
was discharged from hospital 15 days after the bite with persistent limb weakness and urinary
incontinence but eventually recovered. The interesting and unusual features of this case (severe
local pain, very slow evolution of neurotoxic envenoming, persistent thrombocytopenia and mild
coagulopathy) are discussed in the context of what is known of the composition of Micrurus
venoms and the small clinical literature on envenoming from their bites.
© 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights
reserved.
Corresponding author. Tel.: +44 1865 221332/220968;
fax: +44 1865 220984.
E-mail address: david.warrell@ndm.ox.ac.uk (D.A. Warrell).
1. Introduction
The 70 or more species of coral snakes (genera Leptomi-
crurus,Micrurus and Micruroides) are the sole terrestrial
elapid snakes of the Western Hemisphere. They range in
total length from 40 to 150 cm. Although most coral snakes
are strikingly marked with circumferential bands of red,
0035-9203/$ — see front matter © 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.trstmh.2008.03.026
Author's personal copy
1128 S.R. Manock et al.
black, white or yellow they are easily confused with their
many harmless colubrid mimics (Campbell and Lamar, 2004).
Throughout their distribution from the southern United
States south to central Argentina they are responsible for
only a small proportion of snake bites, although the case
fatality, attributable to respiratory paralysis, may be high.
For example, at Hospital Vital Brazil, S˜
ao Paulo, 15 coral
snake bites without any fatalities were admitted between
1902 and 1945; 13 with two fatalities between 1954 and
1965 (Rosenfeld, 1971) and 19 without any fatalities from
1966 to 1979 (Roze, 1996). In the whole of Brazil, only 0.65%
of all snake bites reported from 2001 to 2004 (486 of the
75 312) were attributed to coral snakes, and there were
no fatalities. In the United States and Central America, 3.6
and 2% of snake bites, respectively, were attributed to coral
snakes (Bucaretchi et al., 2006). A variety of local and sys-
temic manifestations of envenoming have been described in
patients bitten by different species of coral snakes (Roze,
1996; Warrell, 2004), but there are few detailed clinical
reports. This is especially true of identified bites by Central
and South American species, such as Micrurus lemniscatus,
which was responsible for the case described here.
2. Case report
A 27-year-old Ecuadorian male biologist employed by a US-
based film company was bitten on the right thumb while
capturing a snake in the eastern jungle of Ecuador near
Shell, Pastaza. He arrived at Hospital Vozandes del Oriente,
a rural mission hospital in Shell, 20 min after being bitten.
The live snake was brought to the hospital. It had alternating
black, red and beige circumferential stripes and was 120 cm
in total length (Figure 1). The patient was extremely anxious
and complained of intense pain and paraesthesiae in the bit-
ten arm. On examination he was a young, well-developed
male who was writhing in pain and sweating profusely. At
the site of the bite there were two small puncture wounds,
approximately 10 mm apart, which were bleeding slightly.
The patient’s vital signs were normal except for tachyp-
noea (temperature 36.8 C, blood pressure 120/78 mmHg,
pulse 70/min, respiratory rate 40/min, oxygen saturation
99% breathing room air). The remainder of the physical
examination was normal except for a small area of non-
erythematous swelling on the upper lip, where he had been
bitten three times by a vampire bat (Desmodus rotundus)on
the previous day. The patient was in the region to make a
documentary about an epidemic of vampire bat rabies in the
Amazon basin (Warner et al., 1999). While handling these
bats for the purpose of filming, he had also been bitten
on the right thumb 2 days previously. Initially, he claimed
to have received pre-exposure vaccination against rabies
(see below) and was given a booster dose of vaccine on the
day before his admission. The admission blood count per-
formed 10 h after the snake bite showed a leucocyte count
of 21 ×109/l with a left shift (4% bands, 93% segmented
cells, 21% lymphocytes, 5% monocytes), haemoglobin of
15.5 g/dl, haematocrit 47% and platelets 86 ×109/l. The
prothrombin time (PT) was 17 (normal range 10—14) s and
partial thromboplastin time (PTT) was 46 (normal range
30—40) s. Plasma sodium concentration was 143 mmol/l,
Figure 1 South American coral snake (Micrurus lemniscatus helleri), 120 cm in total length, responsible for the bite.
Author's personal copy
Neurotoxic envenoming by South American coral snake 1129
Figure 2 The patient 14 h after the bite, showing bilateral
ptosis, facial paralysis, dilated pupils and drooling of saliva.
The patient gave full informed consent for this photograph to
be published exactly as it is, without masking his eyes.
potassium 3.9 mmol/l, calcium 1.9 mmol/l (7.5 mg/dl), ala-
nine aminotransferase 43 U/l, total creatine kinase 256 U/l
and creatinine 79.6 mol/l (0.9mg/dl). Urinalysis was unre-
markable apart from 1+ ketones and 5—10 leucocytes/high
power field.
At this stage, the medical personnel were uncertain
about the identity of the snake and whether the patient was
envenomed. He was admitted to the hospital, but despite
i.v. diazepam 20 mg, ketorolac 60 mg and morphine 3 mg,
his anxiety and pain persisted. Two additional doses of mor-
phine and midazolam were required during the next 7 h, but
by 9 h after the bite the patient was free of pain and anxiety
and had no abnormal neurological signs. He asked to be dis-
charged from hospital but was persuaded to stay. Fourteen
hours after the bite he was found to have bilateral pto-
sis, facial paralysis, horizontal nystagmus, decreased visual
acuity, dysarthria and dysphagia and was drooling saliva
(Figure 2). His pupils were equally dilated to 3—4 mm with
decreased reactivity to light and accommodation. There was
no respiratory distress. His blood clotted within 20 min when
left in a glass tube, making it unlikely that he was severely
envenomed by a pit viper or colubrid snake (Sano-Martins et
al., 1994).
Expert consultation via e-mail confirmed that the snake
involved was Micrurus lemniscatus helleri and so, in
view of unambiguous signs of neurotoxicity, a search was
instigated to obtain an appropriate antivenom. Meanwhile,
i.v. atropine 2 mg and neostigmine 2.5 mg produced no
detectable improvement. The patient’s condition remained
unchanged until 40 h after the bite, when he developed
urinary incontinence. At this time the haematocrit was 46%,
the platelet count was 58 ×109/l and the PT and PTT had
almost returned to normal at 16 and 40 s, respectively. Fifty
hours after the bite, 10 vials of anti-coral antivenom (Costa
Rican Instituto Clodomiro Picado ‘panamerican suero: anti-
coral polyvalente’) were finally obtained and administered
intravenously over 2 h without any reaction. The patient
remained fully alert and had no respiratory difficulty.
At 60 h, the patient began to show progressive weak-
ness of all four limbs and became mildly hypoxic. He was
given oxygen by nasal cannula. A chest radiograph revealed
a small right middle lobe infiltrate, attributed to aspiration,
and a course of i.v. ceftriaxone was begun. A sputum cul-
ture eventually grew fully sensitive Staphylococcus aureus
of uncertain significance. Haematocrit was 52% and platelet
count 90 ×109/l. PT and PTT were within normal limits,
as were the plasma sodium, potassium and creatinine and
serum glutamic oxaloacetic transaminase concentrations.
However, creatine kinase had risen to 749 U/l which, in the
absence of any i.m. injections suggested mild rhabdomy-
olysis. It now emerged that the patient had not received
pre-exposure rabies vaccination. Full post-exposure prophy-
laxis was therefore completed with human rabies immune
globulin and rabies vaccine.
At 72 h, the patient was intubated and mechanically
ventilated because he was requiring more oxygen to main-
tain arterial saturation, had lost the gag reflex and was
exhausted. Six hours later he extubated himself, and was
stable on oxygen 3 l/min by mask for another 7 h. He was now
able to open his eyes to about 70% of normal, could swallow
saliva and make guttural sounds. However, at 85 h sud-
den respiratory distress demanded immediate re-intubation
and resumption of mechanical ventilation. A large left
pneumothorax was confirmed by radiography but the lung
re-expanded after insertion of a chest tube. At 107 h after
the bite the patient was extubated and given supplemen-
tal oxygen by mask. He was fully alert, could open his eyes
completely, was able to speak and swallow and had a gag
reflex. There was increasing strength in his arms, although
his legs remained weak.
At 110 h after the bite, the patient decompensated yet
again. He was re-intubated for a third time and, after the
chest tube had been replaced and pneumothorax excluded
by radiography, he was flown to the capital city in an air-
craft with a pressurized cabin. At Hospital Metropolitano
in Quito, an emergency bronchoscopy was performed to
remove mucus plugs. Two days later he was finally extu-
bated, but weakness in his limbs and urinary incontinence
persisted. He was discharged from hospital 15 days after
the snake bite and went on to make a full and sustained
recovery.
3. Discussion
The South American coral snake M.lemniscatus is widely
distributed in Bolivia, Peru, Ecuador, Colombia, Venezuela,
Trinidad, Guyana, Suriname, French Guinea, Brazil and
Author's personal copy
1130 S.R. Manock et al.
perhaps Paraguay. The subspecies M.l.helleri, which was
responsible for biting our patient, occurs on the Amazonian
slopes and Orinocoan watershed of Colombia, south through
eastern Ecuador, northern Bolivia, southern Venezuela and
northwestern Brazil (Campbell and Lamar, 2004).
In the laboratory, M.lemniscatus venom showed post-
synaptic neurotoxic (Jorge da Silva J´
unior and Bucaretchi,
2003), myotoxic (Guti´
errez et al., 1983, 1992), haemor-
rhagic (Barros et al., 1994), oedema-forming and haemolytic
activities (Cecchini et al., 2005).
Literature on envenoming by M.lemniscatus is limited to
a few case reports (Warrell, 2004). In Trinidad, two men bit-
ten on the lip and tongue by a 137 cm-long M.l.diutius died
7 and 8 h later. Two non-fatal cases of M.lemniscatus bites
were admitted to Hospital Vital Brazil, S˜
ao Paulo between
1954 and 1965 (Rosenfeld, 1971). In Pinheiro, Maranh˜
ao,
Brazil, a patient bitten by M.l.lemniscatus developed paral-
ysis, visual disturbances and internal haemorrhage and died
17 h later (Silva-J´
unior, 1956). In Corumbaibo, Goi´
as, Brazil,
a 61-year-old man bitten by M.l.carvalhoi experienced
severe local pain but did not develop systemic envenoming
(Nishioka et al., 1993). In Sert˜
aozinho, northern S˜
ao Paulo
State, Brazil, a child who put one end of a garden hose in
her mouth was fatally envenomed by a small specimen of
M.l.carvalhoi that was hiding there (Laure et al., 2005).
One of a series of eight cases of Micrurus bites in Campinas,
S˜
ao Paulo State, Brazil was proven to be due to M.l.carval-
hoi, but the patient developed no envenoming (Bucaretchi
et al., 2006). In Amazonian Peru, a 21-year-old man bitten
by an adult M.l.helleri developed ptosis and difficulty in
walking 48 h later. His symptoms persisted for several weeks.
The unusual opportunity to observe and treat a patient
severely envenomed by a South American coral snake in a
well-equipped hospital in rural Ecuador has yielded some
unexpected and interesting findings. First aid for snake-
bite victims is a controversial subject (Gold et al., 2002;
Warrell, 2002), but there is some evidence to support the
use of pressure-immobilization in people bitten by coral
snakes, to delay the development of respiratory paraly-
sis (German et al., 2005). The complete lack of any local
swelling or other changes at the site of the bite is not
remarkable for a coral snake bite. Micrurus venoms differ
in their oedema-forming effects, with the Central American
M.nigrocinctus having the greatest effect clinically and
experimentally (Cecchini et al., 2005; Roze, 1996). Our
patient presented with such severe pain and paraesthesiae
in the bitten limb that, despite repeated doses of morphine
and tranquilizers, he was not relieved of his symptoms until
9 h after the bite. This is reminiscent of the 61-year-old man
reported by Nishioka et al. (1993), who, after a bite by M.l.
carvalhoi, experienced intense bursts of pain up the bitten
arm every few minutes, which persisted for 7 h despite com-
mon analgesics, repeated i.v. meperidine, i.m. diclofenac,
lignocaine local block and oral diazepam. Immediate local
pain and paraesthesiae radiating up the bitten limb have
been mentioned in other accounts of coral snake enven-
oming (Morgan et al., 2007; Rosenfeld, 1971; Roze, 1996).
The dermatomal distribution of these symptoms suggests a
direct action of a venom component on the pain-conducting
C fibres.
On admission to hospital less than 30 min after the
bite, our patient had no clinical evidence of systemic
envenoming, but his blood count showed a marked leuco-
cytosis with left shift, suggesting an early inflammatory
response, thrombocytopenia and mild coagulopathy but
no evidence of abnormal bleeding. Platelet-agglutinating
C-type lectins have been found in venoms of several species
of Asian and Australian elapid snakes (Du et al., 2006),
but Micrurus venoms have not been investigated. The
coagulopathy might be attributable to phospholipase A2
(Barros et al., 1994).
According to Rosenfeld (1971): ‘‘Fatal cases [of coral
snake bite] run their course in less than 6 hours’’, and yet
our patient exhibited no neurotoxic signs until 14 h after
the bite. Respiratory muscle paralysis progressed so slowly
that he did not need oxygen until 60 h, and intubation and
mechanical ventilation until 72 h, after the bite. In one of a
series of 39 cases of M.fulvius bites in Florida, neurotoxic
symptoms were delayed for 13 h but then evolved precipi-
tously, resulting in bulbar and respiratory paralysis (Kitchens
and Van Mierop, 1987). Our patient’s recovery was also slow.
By the time he left the hospital 15 days after the bite, he
was still weak and had urinary incontinence, which may have
been the result of neuromuscular blockade of either somatic
or autonomic innervation of the bladder and sphincter. Other
features of autonomic nervous system activity were his pro-
fuse sweating on admission and later drooling of saliva,
both described in other cases of coral snake envenoming
(Warrell, 2004). However, paralysis of bulbar muscles may
have contributed to the impression of increased salivation.
Delays of 3—6 weeks in recovery from paraesthesiae and
weakness have been mentioned in other reports (Kitchens
and Van Mierop, 1987). Because of the well-documented
delay in appearance of neurotoxic signs following coral
snake bites, patients with proof or suspicion of such
accidents must be carefully observed in hospital for at
least 24 h.
There was no detectable response in our patient’s neu-
rotoxic signs to treatment with either anticholinesterase
or specific antivenom. Anticholinesterase is reported to
have ameliorated paralysis in cases of M.frontalis enven-
oming in Brazil and since the venom of M.lemniscatus
is similar in containing only post-synaptic neurotoxins, it
seemed reasonable to try this treatment (Coelho et al.,
1992;Jorge da Silva J´
unior and Bucaretchi, 2003;Vital Brazil
and Vieira, 1996). A generous dose of Costa Rican Instituto
Clodomiro Picado ‘panamerican suero: anticoral polyva-
lente’ was administered 50 h after the bite. This antivenom
has demonstrated pre-clinical efficacy against venoms of
M.lemniscatus as well as eight other species of coral
snakes (M.fulvius,M.alleni,M.carinicaudus dumerilii,
M.corallinus,M.frontalis,M.mipartitus,M.nigrocinctus
and M.spixii)(Bola˜
nos et al., 1978). Early administration of
antivenom is recommended to allow neutralisation of neuro-
toxins before they have become bound, perhaps irreversibly
in the case of pre-synaptic toxins, to their receptor targets
at neuromuscular junctions. This was the basis of the recom-
mendation in the United States that coral snake antivenom
be given immediately in any case of definite coral snake bite,
even before any signs of envenoming have appeared.
Our patient showed a modest increase in serum creatine
kinase activity, from 256 to 749 U/l, during the first 3
days after the bite. Generalised myalgia with evidence
of gross rhabdomyolysis (serum creatine kinase levels
Author's personal copy
Neurotoxic envenoming by South American coral snake 1131
of up to 18 000 U/l) have been described after human
envenoming by M.fulvius (Kitchens and Van Mierop, 1987)
and also in a patient bitten by M.laticollaris (Pettigrew and
Glass, 1985), as well as in mice injected with venoms of
M.nigrocinctus nigrocinctus,M.n.mosquitensis,M.alleni,
M.frontalis,M.carinicauda and M.surinamensis (Guti´
errez
et al., 1983). Haemolysis has been reported in cases of
envenoming by M.corallinus and M.laticollaris (Pettigrew
and Glass, 1985; Warrell, 2004), but in our patient there
was no fall in haemoglobin concentration.
This case exemplifies the difficulties involved in caring for
snake-bite patients in remote areas of the developing world.
The hospital staff in Shell is experienced in the management
of pit viper bites, mainly by Bothrops atrox and B.bilineatus
(Smalligan et al., 2004), but had no experience with coral
snake bites, this being the first such case ever reported in
the province of Pastaza. Uncertain whether or not they were
dealing with a coral snake bite, and despite the absence of
any specific neurological findings, they wisely admitted the
patient for observation and symptomatic treatment. Four-
teen hours later, typical symptoms of neurotoxic Micrurus
envenoming had developed and the snake was identified
by e-mailing digital photographs to international experts.
There was a disconcerting 2 day delay before coral snake
antivenom could be imported from Costa Rica. Because of
the risk of rapid deterioration in respiratory status, and
mechanical ventilation was available at Hospital Vozandes
del Oriente, the staff and patient’s family decided against
an immediate transfer to a tertiary care facility. However,
the intensive management of this patient was very taxing
on the staff of this small hospital. Finally, after respiratory
distress had occurred three times in 38 h, a costly intensive
care medi-vac flight was arranged. This would have been
unaffordable for the vast majority of patients in this region
of rural Ecuador.
In the case we have described, as in 25% of snake bites
in the United States, a young man was struck while handling
a snake injudiciously (Kitchens and Van Mierop, 1987). Coral
snakes are often mistaken for their colubrid mimics. This
accident could have been prevented if the snake had been
recognised as potentially dangerous and had been left alone
or handled using appropriate care and equipment. It is also
incomprehensible that those involved in filmed contact with
vampire bats during a rabies epidemic lacked pre-exposure
rabies vaccination.
Authors’ contributions: SRM, GS, DG, MLA-A and DAW all
contributed to the patient’s clinical care and assessment,
either on site at Shell Hospital or by telephone and/or
e-mail; SRM and DAW drafted the manuscript, which was
reviewed and augmented by all the authors. All authors
read and approved the final manuscript. DAW and SRM are
guarantors of the paper.
Acknowledgements: SRM wishes to thank his wife for her
patience and forbearance during the most taxing 5 days of
their married life.
Funding: None.
Conflicts of interest: None declared.
Ethical approval: Not required; the assessment and treat-
ment of the patient was part of the standard clinical
procedures at Hospital Vozandes del Oriente, Shell, Pastaza,
Ecuador.
References
Barros, A.C., Fernandes, D.P., Ferreira, L.C., Dos Santos, M.C.,
1994. Local effects induced by venoms from five species of genus
Micrurus sp. (coral snakes). Toxicon 32, 445—452.
Bola˜
nos, R., Cerdas, L., Abalos, J.W., 1978. Venoms of coral snakes
(Micrurus spp.): report on a multivalent antivenin for the Amer-
icas. Bull. Pan Am. Health Organ. 2, 23—27.
Bucaretchi, F., Hyslop, S., Vieira, R.J., Toledo, A.S., Madureira, P.R.,
de Capitani, E.M., 2006. Bites by coral snakes (Micrurus spp.)
in Campinas, State of S˜
ao Paulo, Southeastern Brazil. Rev. Inst.
Med. Trop. Sao Paulo 48, 141—145.
Campbell, J., Lamar, W.W. (Eds.), 2004. Venomous Reptiles of the
Western Hemisphere. Cornell University Press, Ithaca, NY.
Cecchini, A.L., Marcuss, S., Silveira, L.B., Borja-Oliveira, C.R.,
Rodrigues-Simioni, L., Amara, S., St´
abeli, R.G., Giglio, J.R.,
Arantes, E.C., Soares, A.M., 2005. Biological and enzymatic
activities of Micrurus sp. (Coral) snake venoms. Comp. Biochem.
Physiol. A Mol. Integr. Physiol. 140, 125—134.
Coelho, L.K., Silva, E., Espositto, C., Zanin, M., 1992. Clinical fea-
tures and treatment of Elapidae bites: report of three cases.
Hum. Exp. Toxicol. 11, 135—137.
Du, X.Y., Sim, D.S., Lee, W.H., Zhang, Y., 2006. Blood cells as targets
of snake toxins. Blood Cells Mol. Dis. 36, 414—421.
German, B.T., Hack, J.B., Brewer, K., Meggs, W.J., 2005. Pressure-
immobilization bandages delay toxicity in a porcine model of
eastern coral snake (Micrurus fulvius fulvius) envenomation.
Ann. Emerg. Med. 45, 603—608.
Gold, B.S., Dart, R.C., Barish, R.A., 2002. Bites of venomous snakes.
N. Engl. J. Med. 347, 804—805.
Guti´
errez, J.M., Lomonte, B., Portilla, E., Cerdas, L., Rojas, E.,
1983. Local effects induced by coral snake venoms: evidence
of myonecrosis after experimental inoculations of venoms from
five species. Toxicon 21, 777—783.
Guti´
errez, J.M., Rojas, G., da Silva J´
unior, N.J., N´
u˜
nez, J., 1992.
Experimental myonecrosis induced by the venoms of South Amer-
ican Micrurus (coral snakes). Toxicon 30, 1299—1302.
Jorge da Silva J´
unior, N., Bucaretchi, F., 2003. Mecanismo de ac¸˜
ao
do veneno elap´
ıdico e aspectos cl´
ınicos dos acidentes, in: Car-
doso, J.L.C., Franc¸a, F.O.S., Wen, F.H., M´
alaque, C.M.S., Haddad
Jr, V. (Eds), Animais Pec¸onhentos no Brasil. Biologia, Cl´
ınica e
Terapˆ
eutica dos Acidentes. Sarvier & FAPESP, S˜
ao Paulo, Brazil,
pp. 99—107.
Kitchens, C., Van Mierop, L.H.S., 1987. Envenomation by the eastern
coral snake (Micrurus fulvius fulvius). A study of 39 victims. J.
Am. Med. Assoc. 258, 1615—1618.
Laure, C.J., Anzaloni Pedrosa, L.H., Jardim Sandrim, A., 2005. Ven-
omous snakes in the northeast of the state of Sao Paulo (Brazil).
Litteratura Serpentium 25, 6—30.
Morgan, D.L., Borys, D.J., Stanford, R., Kjar, D., Tobleman, W.,
2007. Texas coral snake (Micrurus tener) bites. South. Med. J.
100, 152—156.
Nishioka, S.A., Silveira, P.V., Menzes, L.B., 1993. Coral snake bite
and severe local pain. Ann. Trop. Med. Parasitol. 87, 429—
431.
Pettigrew, L.C., Glass, J.P., 1985. Neurologic complications of a
coral snake bite. Neurology 35, 589—592.
Rosenfeld, G., 1971. Symptomatology, Pathology, and Treatment of
Snake Bites in South America, in: B¨
ucherl, W., Buckley, E.E.,
Deulofeu, V. (Eds), Venomous Animals and their Venoms. Aca-
demic Press, New York, pp. 345—384.
Author's personal copy
1132 S.R. Manock et al.
Roze, J.A., 1996. Coral Snakes of the Americas: Biology, Identifica-
tion, and Venoms. Krieger, Malabar, Florida, USA.
Sano-Martins, I.S., Fan, H.W., Castro, S.C., Tomy, S.C., Franca,
F.O., Jorge, M.T., Kamiguti, A.S., Warrell, D.A., Theakston, R.D.,
1994. Reliability of the simple 20 minute whole blood clot-
ting test (WBCT20) as an indicator of low plasma fibrinogen
concentration in patients envenomed by Bothrops snakes. Butan-
tan Institute Antivenom Study Group. Toxicon 32, 1045—1050.
Silva-J´
unior, M., 1956. O Ofidismo no Brasil. Minist´
erio da Sa´
ude, Rio
de Janeiro, Brazil.
Smalligan, R., Cole, J., Brito, N., Laing, G.D., Mertz, B.L., Manock,
S., Maudlin, J., Quist, B., Holland, G., Nelson, S., Lalloo, D.G.,
Rivadeneira, G., Barragan, M.E., Dolley, D., Eddleston, M., War-
rell, D.A., Theakston, R.D., 2004. Crotaline snake bite in the
Ecuadorian Amazon: randomised double blind comparative trial
of three South American polyspecific antivenoms. Br. Med. J.
329, 1129.
Vital Brazil, O., Vieira, R.J., 1996. Neostigmine in the treatment
of snake accidents caused by Micrurus frontalis: report of two
cases. Rev. Inst. Med. Trop. Sao Paulo 38, 61—67.
Warner, C.K., Zaki, S.R., Shieh, W.J., Whitfield, S.G., Smith, J.S.,
Orciari, L.A., Shaddock, J.H., Niezgoda, M., Wright, C.W.,
Goldsmith, C.S., Sanderlin, D.W., Yager, P.A., Rupprecht, C.E.,
1999. Laboratory investigation of human deaths from vam-
pire bat rabies in Peru. Am. J. Trop. Med. Hyg. 60, 502—
507.
Warrell, D.A., 2002. Bites of venomous snakes. N. Engl. J. Med. 347,
1804—1805, author reply 1804—1805.
Warrell, D.A., 2004. Epidemiology, clinical features and man-
agement of snake bites in Central and South America, in:
Campbell, J., Lamar, W.W. (Eds), Venomous Reptiles of the West-
ern Hemisphere. Cornell University Press, Ithaca, NY, pp. 709—
761.
... En la Amazonía ecuatoriana, las especies venenosas que predominan son Bothrops atrox y B. bilineatus smaragdinus, conocidas popularmente como "equis o pitalala" y "lorito machacui", respectivamente (6,7). Las mordeduras por serpientes del género Micrurus "corales" son raras (4,6,8). ...
... Las 29,4 hospitalizaciones anuales durante los últimos cinco años en el Hospital General "Marco Vinicio Iza", demuestran que las mordeduras de serpientes en esta región del norte amazónico del Ecuador son endémicas y constituyen un problema de salud pública. Pocos y desactualizados son los estudios en la Amazonía ecuatoriana (7)(8)(9)(10)15,22,23). ...
... No se reportó ningún caso por Micrurus (corales) de la familia Elapidae, lo cual concuerda la rareza de estos accidentes según datos del Ministerio de Salud Pública (6) y esto fue confirmado clínicamente sin sintomatología de neurotoxicidad. Sin embargo, existen reportes anecdóticos de mordeduras y la presencia de especies como Micrurus helleri en la región amazónica (6,7,8). Las especies de la familia Viperidae implicadas está acorde con las que predominan en la Amazonía ecuatoriana, Bothrops atrox y B. bilineatus smaragdinus (6,7). ...
Article
Full-text available
Introducción. En Ecuador, las mordeduras de serpientes venenosas son un problema de salud pública. Sin embargo, no existe información hospitalaria reciente desde la Amazonía. Objetivo. Analizar retrospectivamente las características clínico-epidemiológicas de las mordeduras de serpientes en pacientes ingresados en un hospital de la Amazonía del Ecuador. Materiales y métodos. Se llevó a cabo un estudio transversal en el hospital provincial de Nueva Loja (Sucumbíos), que colinda con Colombia, 2017-2021. La información sobre las variables demográficas, epidemiológicas y clínicas, y la condición al egreso hospitalario, se obtuvieron de la ficha epidemiológica del Ministerio de Salud Pública. Resultados. En cinco años se hospitalizaron 147 pacientes (29,4 por año), sin que se presentaran muertes. Corresponden a 26, 34, 32, 29 y 26 casos, en el 2017, 2018, 2019, 2020 y 2021, respectivamente. Según el sexo, los más afectados fueron los hombres (n=99; 67,3 %), según el grupo etario, los de 21 a 30 años (n=28; 19,0 %) y, según la raza, los de etnia mestiza (n=94; 63,9 %), estudiantes y agricultores. La mediana de edad fue de 28 años (rango: 4 a 81). Hubo mayor prevalencia en abril, junio y septiembre. Todos los accidentes fueron causados por serpientes Viperidae. Veinte (13,6 %) casos fueron leves, 90 (61,2 %), moderados, y 37 (25,2 %), graves. La mordedura fue más frecuente en los pies (45 casos). El 53,1 % recibió suero antiofídico antes de la hospitalización y en el 19,8 % de los pacientes se colocó un torniquete. La mediana de tiempo de llegada al hospital fue de 5 horas (rango: 1-192), y lo más frecuente fue entre 2 y 3 horas (41 casos). No se encontraron diferencias estadísticamente significativas según la gravedad del caso. Conclusiones. Se evidenció una gran prevalencia de mordeduras de serpientes en el norte de la región amazónica-Ecuador, con mayor incidencia en la estación lluviosa y todas causadas por Viperidae. Es importante resaltar la mortalidad nula. Las campañas informativas sobre prevención y primeros auxilios, como la desmotivación del uso de torniquetes, serían fundamentales para reducir los casos, especialmente, en los grupos vulnerables.
... The most relevant clinical manifestations elicited by the venom of Micrurus species are those related to neuromuscular impairment, and coagulopathies have not been reported [63,64]. Nevertheless, envenomation by M. lemniscatus helleri [65] induces a slight prolongation in prothrombin (PT) and partial thromboplastin time (PTT) along with mild thrombocytopenia (from 83 to 41 × 10 9 cells/L). Envenomation by M. annellatus causes the blood to be incoagulable for two days after the bite even after the administration of antivenom; slight thrombocytopenia (from 164 to 133 × 10 3 cell/mL) has also been observed [66]. ...
Article
Full-text available
Little is known of the biochemical composition and functional features of the venoms of poorly known Colombian coral snakes. Here, we provide a preliminary characterization of the venom of two Colombian endemic coral snake species, Micrurus medemi and M. sangilensis, as well as Colombian populations of M. helleri. Electrophoresis and RP-HPLC techniques were used to identify venom components, and assays were conducted to detect enzyme activities, including phospholipase A2 , hyaluronidase, and protease activities. The median lethal dose was determined using murine models. Cytotoxic activities in primary cultures from hippocampal neurons and cancer cell lines were evaluated. The venom profiles revealed similarities in electrophoretic separation among proteins under 20 kDa. The differences in chromatographic profiles were significant, mainly between the fractions containing medium-/large-sized and hydrophobic proteins; this was corroborated by a proteomic analysis which showed the expected composition of neurotoxins from the PLA2 (~38%) and 3FTx (~17%) families; however, a considerable quantity of metalloproteinases (~12%) was detected. PLA2 activity and protease activity were higher in M. helleri venom according to qualitative and quantitative assays. M. medemi venom had the highest lethality. All venoms decreased cell viability when tested on tumoral cell cultures, and M. helleri venom had the highest activity in neuronal primary culture. These preliminary studies shed light on the venoms of understudied coral snakes and broaden the range of sources that could be used for subsequent investigations of components with applications to specific diseases. Our findings also have implications for the clinical manifestations of snake envenoming and improvements in its medical management.
... The victim of Case 1 was quickly discharged from the hospital because the medical team, based on the absence of systemic manifestations, assumed that the snake was non-venomous, since many harmless species mimic coral snakes and may show local manifestations (Buononato et al., 2021;Menegucci et al., 2019). But the patient should have been kept in observation for at least 24 hours, regardless of symptoms (Bucaretchi et al., 2016(Bucaretchi et al., , 2021Bisneto et al., 2020b), because manifestations related to severity can appear more than 12 hours after the bite (Bisneto et al., 2020b;Manock et al., 2008). Only after the snake was identified as a Micrurus was the patient called back to the medical center. ...
Article
Herein, we report three new separate cases of human envenomations by Micrurus hemprichii for the Amazon, which is a biome where envenomations by Micrurus are seldom reported. Two women were bitten after stepping on the snakes and one man was bitten while handling the animal. All cases occurred in the peridomicile, in rural areas. The first case evolved mainly to local symptoms, but the patient was discharged before the identification of the snake and had to be called back for observation before being eventually discharged. In the second case, the patient presented transitory dyspnea and she was discharged after four days in hospital. In the third case, the patient showed only local symptoms, but he was about to receive unnecessary antivenom against coral snakes. Cases like these show the importance of educational problems regarding local venomous snakes in order to avoid bites and to provide the correct hospital treatment. For this, trained professionals in cases involving venomous animals are needed.
... Ecuadorian Micrurus snakebites have received little attention in the literature. To date, only one case report detailing the main manifestations following a M. helleri envenomation in Ecuador has been documented [33]. Neurotoxic effects and a mild increase in the levels of serological muscle damage biomarker (creatine kinase) were observed. ...
Article
Full-text available
Micrurus is a medically relevant genus of venomous snakes composed of 85 species. Bites caused by coral snakes are rare, but they are usually associated with very severe and life-threatening clinical manifestations. Ecuador is a highly biodiverse country with a complex natural environment, which is home to approximately 20% of identified Micrurus species. Additionally, it is on the list of Latin American countries with the highest number of snakebites. However, there is no local anti-venom available against the Ecuadorian snake venoms, and the biochemistry of these venoms has been poorly explored. Only a limited number of samples collected in the country from the Viperidae family were recently characterised. Therefore, this study addressed the compositional patterns of two coral snake venoms from Ecuador, M. helleri and M. mipartitus, using venomics strategies, integrating sample fractionation, gel electrophoresis, and mass spectrometry. Chromatographic and electrophoretic profiles of these snake venoms revealed interspecific variability, which was ascertained by mass spectrometry. The two venoms followed the recently recognised dichotomic toxin expression trends displayed by Micrurus species: M. helleri venom contains a high proportion (72%) of phospholipase A2, whereas M. mipartitus venom is dominated by three-finger toxins (63%). A few additional protein families were also detected in these venoms. Overall, these results provide the first comprehensive views on the composition of two Ecuadorian coral snake venoms and expand the knowledge of Micrurus venom phenotypes. These findings open novel perspectives to further research the functional aspects of these biological cocktails of PLA2s and 3FTxs and stress the need for the preclinical evaluation of the currently used antivenoms for therapeutic purposes in Ecuador.
... The presence of Andean mountains creates a high diversity of environmental niches, which results in high levels of biodiversity, almost 70% of Ecuadorian terrain is characterized as tropical and subtropical climates where 238 species of snakes are found, of those, 55 snakes are endemic and 37 snakes are venomous (Torres-Carvajal et al., 2018). In Ecuador ophidic accidents are reported more frequently during the rainy season, they are represented mainly by the Elapidae and Viperidae families (Table 2), several species of Bothrops are responsible for the major number of accidents (70-80%) nationwide, followed by Bothrocophias microphthalmus, Bothrops bilineatus, Bothrops taeniata, Lachesis muta and unusual cases caused by the family Elapidae as Micrurus lemniscatus (less than 1%) (Manock et al., 2008;Ministerio de salud pública de Ecuador, 2017;Praba-Egge et al., 2003) (Table 2). ...
Article
Snakebite envenomation is a global health problem. This health problem asymmetrically affects rural populations in developing countries to such an extent that it recently has been listed as a priority neglected tropical disease (NTD). It is estimated that 5.4 million individuals are bitten by snakes each year, causing at least 2.7 million envenomations and more than 100,000 deaths each year. Ecuador has one of the highest snakebite envenomation incidence rates in Latin America, mostly in the coastal and Amazonian provinces. Envenomations in these regions are the result of bites primarily by species of snakes belonging to the Viperidae family. Ecuador was able to locally produce antivenoms, however serious flaws were revealed in the antivenom production process, leading to the decommissioning of the existing facility. In the interest of public health, we have summarized the political and social setbacks experienced by the antivenom serum production plant in Ecuador, while encouraging resuming local production of snake antivenom to improve the responsiveness of the already overburdened health system.
... They induce acute neurotoxicity, leading to respiratory paralysis and death (Kitchens and Van Mierop, 1987;Gutierrez et al., 2009;Corrêa-Netto et al., 2011;Zornetta et al., 2012;Foo et al., 2019). Experimental studies with Micrurus venoms reported myotoxic effects in mice (de Roodt et al., 2012) but only a few human cases have been documented compatible with the experimental myotoxicity observed (Manock et al., 2008;Bucaretchi et al., 2016). Unlike other types of venoms such as bothropic venoms (e.g., B. alternatus, B. asper, or B. atrox species) that provoke tissue destruction and a strong inflammatory response due to their proteolytic and cytotoxic components (Teixeira et al., 2009, Gutierrez et al., 20102018), neurotoxic venoms may frequently lead to severe envenomation followed by death. ...
Article
In South America there are three snake genera with predominantly neurotoxic venoms: Crotalus, Micrurus and Hydrophis, which include nine species/subspecies, 97 species and a single marine species, respectively. Although accidents with neurotoxic venoms are less frequent than those with anticoagulant, cytotoxic or necrotic venoms (e.g. from Bothrops), they are of major public health importance. Venoms from genus Crotalus have been extensively studied, while data on the venoms from the other two genera are very limited, especially for Hydrophis. The venoms of North and South American Crotalus species show biochemical and physiopathological differences. The former species cause bothrops-like envenomation symptoms, while the latter mainly have neurotoxic and myotoxic effects, leading to respiratory paralysis and, occasionally, renal failure by myoglobinuria and death, often with no local lesions. Micrurus and Hydrophis also cause neurotoxic envenomations. Many studies have isolated, identified and characterized new enzymes and toxins, thus expanding the knowledge of snake venom composition. The present review summarizes the currently available information on neurotoxic venoms from South American snakes, with a focus on protein composition and toxicological properties. It also includes some comments concerning potential medical applications of elapid and crotalic toxins.
... Snakes from Micrurus genus are known for severe envenomation with significant neurological impairment [14]; however, its cardiotoxic effects, especially its arrhythmogenic potential, were scarcely studied. To date, information regarding cardioactive potential of Micrurus venom has only been reported for M. fulvius [15][16][17], M. frontalis [7,18] and M. lemniscatus (2020) [9]. ...
Article
Full-text available
Micrurus surinamensis is a coral snake from the Elapidae family of wide distribution in Amazonia Forest. Its venom contains neurotoxins that induce muscular and respiratory paralysis; however, its cardiovascular action is not yet characterized. The aim of this study was to investigate the cardiotoxic effects caused by M. surinamensis poisoning in rodents. Twelve guinea pigs (Cavia porcellus) were distributed in two groups (n = 6) named as control and envenomed. The control group received 0.2 ml of PBS/BSA via intramuscular injection (IM), while envenomed animals received 0.75 µg of venom per g of body weight, also via IM. Electrocardiographic examination (ECG) and biochemical serum tests were conducted before and 2 h after inoculation. ECG of the envenomed animals revealed severe progressive arrhythmias including atrioventricular block, supraventricular, and ventricular extrasystoles. Serum biochemistry showed significant increase in CK, CK-MB, and LDH enzymes corroborating the skeletal and cardiac muscle damage. Myonecrosis and degeneration were observed in both skeletal and heart muscle; nevertheless, transmission electron microscopy revealed cardiac muscle fibers fragmentation. In conclusion, M. surinamensis venom has a potent cardiotoxic activity eliciting arrhythmogenic effects and heart damage after only 2 h of envenomation.
... 14 , 15 Mild elevations of creatine phosphokinase, rhabdomyolysis, and coagulopathy have been reported in envenomations by the South American coral snake Micrurus lemniscatus helleri and the Asian banded coral snake Calliophis intestinalis, and patients bitten by these species will benefit from a more extensive laboratory workup than patients bitten by M fulvius. 4,16,17 Snake venom lethality is described using the term median lethal dose, or LD50. The LD50 indicates the amount of venom needed to kill 50% of the test population if untreated, with a lower LD50 indicating a more lethal venom. ...
Article
We present the case of a patient who developed myalgia as the primary symptom of envenomation by the eastern coral snake, Micrurus fulvius. The patient was evaluated and treated in the emergency department. Physical examination did not demonstrate any neuromuscular abnormalities. On consultation with the poison control center, the patient’s myalgia was determined to be an effect of envenomation, and 5 vials of North American coral snake antivenin were administered. The patient was admitted to the intensive care unit where his symptoms resolved. He was discharged the following day after remaining asymptomatic for 24 h.
... Some ancillary research has focused on other aspects of their venom, including observations that some coral snake venoms have anticoagulant effects on blood (Cecchini et al., 2005;Oliveira et al., 2017;Rey-Suárez et al., 2017). Additionally, some bite reports from the genus indicate mild to moderate disturbances to the victim's hemostasis (Manock et al., 2008;Strauch et al., 2018;Silva et al., 2019), though there is no direct evidence that these symptoms were caused by venom proteins rather than preexisting conditions in the patients or as a result of their ongoing treatment in the hospital. Of those patients showing these coagulopathies, all display delayed clotting times or wholly unclottable blood. ...
Article
Snakebite is a neglected tropical disease with a massive global burden of injury and death. The best current treatments, antivenoms, are plagued by a number of logistical issues that limit supply and access in remote or poor regions. We explore the anticoagulant properties of venoms from the genus Micrurus (coral snakes), which have been largely unstudied, as well as the effectiveness of antivenom and a small-molecule phospholipase inhibitor—varespladib—at counteracting these effects. Our in vitro results suggest that these venoms likely interfere with the formation or function of the prothrombinase complex. We find that the anticoagulant potency varies widely across the genus and is especially pronounced in M. laticollaris. This variation does not appear to correspond to previously described patterns regarding the relative expression of the three-finger toxin and phospholipase A2 (PLA2) toxin families within the venoms of this genus. The coral snake antivenom Coralmyn, is largely unable to ameliorate these effects except for M. ibiboboca. Varespladib on the other hand completely abolished the anticoagulant activity of every venom. This is consistent with the growing body of results showing that varespladib may be an effective treatment for a wide range of toxicity caused by PLA2 toxins from many different snake species. Varespladib is a particularly attractive candidate to help alleviate the burden of snakebite because it is an approved drug that possesses several logistical advantages over antivenom including temperature stability and oral availability.
Article
We developed experimental equine polyvalent and monovalent antivenoms against the venoms of Micrurus (M.) fulvius, M. nigrocinctus and M. surinamensis and studied their immunochemical reactivity on the venoms used as immunogens and on M. pyrrhocryptus, M altirostris and M. balyocoriphus venoms. Assessment of the neutralizing capacity of the polyvalent experimental antivenom was based on inhibition of lethality (preincubation and rescue assay experiments in mice) and indirect hemolytic and phospholipase activities. The immunochemical reactivity and neutralizing capacity were compared with those of two therapeutic antivenoms used for the treatment of coral snake envenomation in North America and in Argentina. In general, the experimental antivenom conferred a comparable level of neutralization against the venoms used as immunogens when compared to the therapeutic antivenoms and a certain level of cross-neutralization against the other venoms. The results suggest the need for additional venoms in the immunogenic mixture used, in order to obtain a broad spectrum anti-Micrurus antivenom with a good neutralizing potency. Paraspecific neutralization of South American coral snake venoms, although present at a higher level than the neutralization conferred by available nonspecific Micrurus therapeutic antivenoms, was rather low in relation to the specific neutralizing capacity.
Article
Full-text available
O soro antipeçonhento específico para ser eficaz no tratamento dos acidentes causados pelas cobras corais deve ser administrado logo após a mordedura, uma vez que as neurotoxinas da peçonha são absorvidas muito rapidamente. Como isto não é sempre possível, outras formas de tratamento, além do soroterápico, devem ser empregadas para evitar a asfixia e morte do paciente. A administração da neostigmina e a respiração artificial são utilizadas com esse objetivo. A neostigmina restabelece a transmissão neuromuscular se o efeito da peçonha resultar de interação reversível de suas neurotoxinas com os receptores da placa terminal. É esse o mecanismo da ação das neurotoxinas da peçonha de M. frontalis de serpentes do centroeste e sul do Brasil, e da Argentina. Em conseqüência a neostigmina antagoniza o bloqueio neuromuscular produzido pela peçonha dessas serpentes e é muito eficaz no tratamento do envenenamento experimental de cães e símios. Na presente comunicação relatamos dois acidentes causados por M. frontalis, tratados com a administração do soro específico e da neostigmina. Nos dois pacientes a administração da neostigmina produziu regressão completa dos fenômenos de paralisia, confirmando sua eficiência demonstrada no tratamento do envenenamento experimental de animais.
Article
Full-text available
To compare the efficacy and safety of three polyspecific antivenoms for bites by pit vipers. Randomised double blind comparative trial of three antivenoms. Shell, Pastaza, southeastern Ecuador. 210 patients with incoagulable blood were recruited from 221 consecutive patients admitted with snake bite between January 1997 and December 2001. One of three antivenoms manufactured in Brazil, Colombia, and Ecuador, chosen for their preclinical potency against Ecuadorian venoms. Permanent restoration of blood coagulability after 6 and 24 hours. The snakes responsible for the bites were identified in 187 cases: 109 patients (58%) were bitten by Bothrops atrox, 68 (36%) by B bilineatus, and 10 (5%) by B taeniatus, B brazili, or Lachesis muta. Eighty seven patients (41%) received Colombian antivenom, 82 (39%) received Brazilian antivenom, but only 41 (20%) received Ecuadorian antivenom because the supply was exhausted. Two patients died, and 10 developed local necrosis. All antivenoms achieved the primary end point of permanently restoring blood coagulability by 6 or 24 hours after the start of treatment in > 40% of patients. Colombian antivenom, however, was the most effective after initial doses of 20 ml (two vials), < 70 ml, and any initial dose at both 6 and 24 hours. An initial dose of 20 ml of Colombian antivenom permanently restored blood coagulability in 64% (46/72) of patients after 6 hours (P = 0.054 compared with the other two antivenoms) and an initial dose of < 70 ml was effective at 6 hours (65%, P = 0.045) and 24 hours (99%, P = 0.06). Early anaphylactoid reactions were common (53%, 73%, and 19%, respectively, for Brazilian, Colombian, and Ecuadorian antivenoms, P < 0.0001) but only three reactions were severe and none was fatal. All three antivenoms can be recommended for the treatment of snakebites in this region, though the reactogenicity of Brazilian and Colombian antivenoms is a cause for concern.
Article
Full-text available
This report describes two accidents, involving snakes of the Micrurus corallinus species, where compromising respiratory function was not observed and the specific anti-elapidic serum was the single therapy used, and a third incident, probably involving Micrurus frontalis, where neostigmine was used to remedy respiratory failure.
Article
A simple whole blood clotting test (WBCT20) was assessed for its efficacy in determination of severe defibrinogenation in patients envenomed by Bothrops snakes in Brazil. There was a close relationship between the results of the WBCT20 and plasma fibrinogen levels in 69 moderately envenomed patients. The advantage of the WBCT20 over estimation of plasma fibrinogen concentrations in patients is that it is a simpler, faster and more reliable test. It is also of use in assessing the effectiveness of antivenom therapy in relation to the restoration of blood coagulability.
Article
A multivalent coral snake antivenin was prepared in horses immunized with a mixture of venoms from the species Micrurus nigrocinctus, M. mipartitus, and M. frontalis, following immunization procedures previously reported (2). Plasma from the horses was fractionated with ammonium sulfate. The antivenin produced was then tested against venoms from ten species. The neutralization titers obtained indicate it would be useful in treating bites received from most of the important coral snake species in North and South America, namely: M. fulvius, M. alleni, M. carinicaudus dumerilii, M. corallinus, M. frontalis, M. lemniscatus, M. mipartitus, M. nigrocinctus, and M. spixii. The authors note that appropriate cooperation by scientists in various countries would make production of this antivenin an easy matter, and that the product could conveniently be distributed via PAHO or other international agencies. They also note that the antivenin showed no significant neutralizing effect against M. surinamensis venom. This situation would appear to justify preparing a monovalent antivenin against M. surinamensis, or else including M. surinamensis venom in an immunization formula for a multivalent antidote.